Results 41 to 50 of about 25,820 (298)

Implementation and effectiveness of an intensive education program on phosphate control among hemodialysis patients: a non-randomized, single-arm, single-center trial

BMC Nephrology, 2021
Background Hyperphosphatemia is a common complication in patients on maintenance hemodialysis. Patients’ adherence to phosphorus control can be improved by consistent education.
Jinmei Yin, Jun Yin, Rongli Lian, Peiqiu Li, Jing Zheng   +4 more
doaj   +1 more source

Prognostic importance of plasma total magnesium in a cohort of cats with azotemic chronic kidney disease [PDF]

, 2018
BACKGROUND: Hypomagnesemia is associated with increased mortality and renal function decline in humans with chronic kidney disease (CKD). Magnesium is furthermore inversely associated with fibroblast growth factor 23 (FGF23), an important prognostic ...
Andrukhova, Andrukhova, Andrukhova, Angelen, Atarashi, Baaij, Barber, Barber, Barber, Barnes, Barr, Bateman, Blaine, Boyd, Bressendorff, Chakrabarti, Chakrabarti, Cheng, Covic, Cunha, Diaz-Tocados, DiBartola, Elin, Elliott, Geddes, Geddes, Geddes, Geddes, Geiger, Ichihara, Iguchi, Isakova, Ishimura, Ishimura, Jahnen-Dechent, Jensen, Jepson, Joffres, Joosten, Kanbay, Kass, King, Kisters, Laecke, Laecke, Laecke, Lawson, Louvet, Lulich, Ma, Matsuzaki, Matsuzaki, McLeland, Meema, Moe, Moe, Mutsert, Nakayama, Navarro-Gonzalez, Norris, Pearson, Plantinga, Resnick, Ross, Ross, Sakaguchi, Sakaguchi, Sakaguchi, Sakaguchi, Sakaguchi, Sakaguchi, Salem, Satake, Shimada, Slatopolsky, Sontia, Toll, Touyz, Williams, Wooldridge, Yogi, Zhang   +81 more
core   +1 more source

Estrogen inhibits renal Na-Pi Co-transporters and improves klotho deficiency-induced acute heart failure

Redox Biology, 2021
Objective and hypothesis: Klotho is an aging-suppressor gene. Mutation of Klotho gene causes hyperphosphatemia and acute heart failure. However, the relationship of hyperphosphatemia and acute heart failure is unclear.
Kai Chen, Zhongjie Sun
doaj  

Evaluation of a Phosphate Management Protocol to Achieve Optimum Serum Phosphate Levels in Hemodialysis Patients [PDF]

, 2008
Original article can be found at: http://www.sciencedirect.com/science/journal/10512276 Copyright National Kidney Foundation, Inc. DOI: 10.1053/j.jrn.2008.05.003To evaluate the effectiveness of a protocol designed to optimize serum phosphate levels in ...
Cheung, C.F., Cunningham, J., Fan, S., Glass, G., Madden, A.M., Yokum, D.   +5 more
core   +1 more source

An expert update on novel therapeutic targets for hyperphosphatemia in chronic kidney disease: preclinical and clinical innovations

Expert opinion on therapeutic targets, 2020
Introduction: The management of hyperphosphatemia in patients with chronic kidney disease (CKD) is complicated, requiring a multidisciplinary approach that includes dietary phosphate restriction, dialysis, and phosphate binders.
M. Cozzolino, M. Ketteler, C. Wagner
semanticscholar   +1 more source

The Relationship between Knowledge about Phosphorus, Dietary Phosphorus Intake and Serum Phosphorus Level in Maintenance Hemodialysis Patients

Journal of High Institute of Public Health, 2022
Background: Renal diet knowledge -especially phosphorus knowledge- is generally poor in Maintenance Hemodialysis (MHD) patients due to the complexity of information about dietary phosphorus thus causing poor compliance to dietary phosphorus guidelines ...
Rana H. Emara, Doha M. Abo Zahra
doaj   +1 more source

Cardiovascular problems in dialysis patients - focus on correcting hyperphosphatemia

Медицинский совет, 2020
Mineral-bone disorder in chronic kidney disease (CKD-MBD) is one of the most important factor determining prognosis in dialysis patients. CKD-MBD syndrome occurs at the CKD stage 2 and reaches its maximum in patients with end-stage renal disease ...
A. M. Essaian, A. R. Rind
doaj   +1 more source

Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 Trial.

Journal of the American Society of Nephrology, 2019
BACKGROUND Guidelines recommend reducing elevated serum phosphate in patients with CKD. Tenapanor, a minimally absorbed inhibitor of gastrointestinal sodium/hydrogen exchanger 3 (NHE3), reduces paracellular phosphate transport.
G. Block, D. Rosenbaum, Andrew T. Yan, G. Chertow   +3 more
semanticscholar   +1 more source

Total Parathyroidectomy with Subcutaneous Parathyroid Forearm Autotransplantation in the Treatment of Secondary Hyperparathyroidism: A Single-Center Experience. [PDF]

, 2018
Introduction Secondary hyperparathyroidism is common in chronic kidney disease. Parathyroidectomy is indicated in refractory hyperparathyroidism when medical treatments and so the parathyroid hormone levels cannot be lowered to acceptable values without
Casella, Claudio, Dimko, Mira, Galani, Alessandro, Lai, Silvia, Ministrini, Silvia, Nazario Portolani, And, Totaro, Luigi   +6 more
core   +1 more source

Research advances on the pathogenesis of vascular calcification caused by hyperphosphatemia associated with chronic kidney disease

Linchuang shenzangbing zazhi
Phosphorus is one of essential nutrients for the human body that plays an indispensable role in various physiological processes. The balance of blood phosphorus is crucial in all living organisms.
Wang Yu-han, Su Ji-li, Zhou Xiao-shuang
doaj   +3 more sources